We seek to improve global cardiovascular health and healthcare across the spectrum of disease prevention.
Cardiovascular diseases are the leading cause of death and disability globally. Out of 54 million deaths each year, one-third (18 million) are caused by some form of cardiovascular disease. As of 2015, there are an estimated 422 million individuals living with prevalent cardiovascular diseases, with 7 million fatal heart attacks and 9 million fatal strokes each year. Most (80 percent) events occur in low- or middle-income country settings where they are also more likely to occur prematurely (younger than 70 years).
The Center for Global Cardiovascular Health aims to bridge the gap between the world we live in and the world we aim to get to. Imagine a world where every person who has an acute cardiovascular event receives timely, high-quality care no matter where they live, where individuals with cardiovascular disease are supported to optimize their health behaviors and adherence to simpler, lower-cost medications that are tailored to their needs, where the food supply supports cardiovascular health and almost no one uses tobacco. This picture is very different than the world in which we live where individuals who have acute cardiovascular diseases receive highly heterogeneous care, where most individuals with cardiovascular disease take zero medications to prevent a recurrent event, where the food supply is rife with junk food and where 20 percent of the world uses tobacco.
"What will it take to get us from where we are now to a world where ideal cardiovascular health and health care are normative? This fundamental question drives the center’s vision and collective actions."
– Mark Huffman, MD, MPH, Director, Center for Cardiovascular Health
Northwestern Faculty and Staff: PI Mark Huffman, MD, MPH, and Jody D Ciolino, PhD; Abigail Baldridge, MS; Namratha R. Kandula, MD, MPH; Donald M. Lloyd-Jones, MD, ScM; Stephen D. Persell, MD, MPH; James Paparello, MD; Swapna Dave, MPH, PMP, MBBS; Sadiya Khan, MD, MS; Mianzhao Guo
QUARTET USA is a phase II randomized trial testing the effect of a four-drug, quarter-dose blood pressure lowering combination among individuals with hypertension in federally qualified health centers in Chicago as part of the global QUARTET program (trial ongoing in Australia and in development in The Netherlands and Japan). This trial represents a reverse innovation of using fixed-dose combination, or polypill, therapy for cardiovascular disease prevention within a U.S. population that bears one of the highest burdens of hypertension-related illness in the world.
learn moreSee Siddique Faculty Profile
Transforming Hypertension Control in Nigeria
Northwestern Faculty and Staff: Mark Huffman, MD, MPH; Lisa Hirschhorn, MD, MPH; Abigail Baldridge, MS; Namratha R Kandula, MD, MPH; C. Hendricks Brown, PhD; Mianzhao Guo
This project will contextualize, implement and evaluate the effect of a large-scale, multi-level hypertension control program intervention in 50 primary health centers in Nigeria in partnership with the University of Abuja and Resolve to Save Lives.
Learn MoreLearn More
International Ten-Day Teaching Teaching Seminars in Cardiovascular Disease Epidemiology and Prevention: 2020Northwestern Faculty and Staff: Darwin Labarthe, MD, PhD, MPH
; Jeremiah Stamler, MD
Cardiovascular diseases and stroke are the leading cause of death and disability in most countries in the world, as they have been over many decades. To address this global health challenge, the seminars were founded in 1968 by Professors Jeremiah and Rose Stamler and Richard Remington from the USA, and Professor Geoffrey Rose from the UK. Initial support was provided by the International Society and Federation of Cardiology (since 1998, World Heart Federation) Council on Epidemiology and Prevention and the Cardiovascular Disease Unit of the World Health Organization in Geneva. From 2008, the sponsor has been the International Society of Cardiovascular Disease Epidemiology and Prevention (ISCEP). The 50th International Seminar was convened in Goa, India, in 2018, and plans are being made for the 51st and beyond.
Heart Attack Care in India
"Acute Coronary Syndrome Quality Improvement in Kerala"
Northwestern Faculty and Staff: PI Mark Huffman, MD, MPH; Abigail Baldridge, MS; Donald M. Lloyd-Jones, MD, ScM; Lihui Zhao, PhD
This stepped wedge, cluster randomized trial was the largest cardiovascular randomized trial in India and demonstrated improvements in process measures among 21,374 patients with heart attacks who were recruited from 63 hospitals in Kerala, India, from 2014 to 2016. The trial also reported health-related quality of life and individual- and household-level costs among heart attack survivors and served as a training hub/model for seven Fogarty-funded Northwestern global health fellows.
Learn more about the program
World Heart Federation
"World Heart Federation Salim Yusuf Emerging Leaders Programme"
Northwestern Faculty and Staff: Mark Huffman, MD, MPH; Darwin Labarthe, MD, PhD, MPH; Abigail Baldridge, MS; Namratha R. Kandula, MD, MPH
This first-of-its-kind training program in implementation science, health systems and health policy was co-created by Huffman, Labarthe and Salim Yusuf in 2014. The program has trained 125 Emerging Leaders from 49 countries over its first five years and features a rotating theme each year.
Improving Access to Essential Cardiovascular Medicines
Northwestern Faculty: Mark Huffman, MD, MPH
The Center for Global Cardiovascular Health aims to improve access to essential cardiovascular medicines by working through the World Health Organization and national model lists of essential medicines and has contributed to the addition of clopidogrel and direct oral anticoagulants to the World Health Organization list, among other changes. An independent study course is offered through the Program in Public Health for students to develop and submit applications to the World Health Organization’s list on a biennial basis.
What will it take to get us from where we are now to a world where ideal cardiovascular health and health care are normative?
This fundamental question drives the Center’s vision and collective actions. This global problem requires a global, comprehensive and cohesive solution that spans the entire spectrum of prevention to reach every person on the planet. The United Nations has set a goal of reducing the risk of premature death from chronic diseases like cardiovascular diseases by one-third by 2030, and the Center’s activities outlined below provide a roadmap to achieve this goal and ultimately end cardiovascular diseases.
- Achieve tobacco endgame where less than 5 percent of the world’s population uses tobacco.
- Improve the healthfulness and sustainability of the global food supply.
- Develop, test, implement and scale novel strategies for global CVD prevention and control, including medicines that simplify care, support from non-physician health workers and technology-based surveillance and interventions.
- Create training and knowledge networks for world-class cardiovascular care anywhere in the world by leveraging resources and expertise from both Northwestern University and Northwestern Medicine.
- Learn, develop, test and implement new scalable research methods, diagnostics for rapid phenotyping and interventions through collaborative breakthrough research with a broad range of scientists, including faculty, trainees and staff at the Northwestern University and its partners.
- Improve the quality and safety of cardiovascular care in low- and middle-income countries through research and training in implementation science, health systems strengthening and health policy.
- Train the next generation of global cardiovascular scientists, practitioners, administrators, policymakers and leaders from the United States and abroad.
Back to top
Be a part of our future commitment to improving the lives of patients around the world. Giving